NEXTBIOMEDICAL Non-Registered Director Nam Dong-heun Acquires 1,000 Common Shares Through Open Market Purchase, Negligible Impact on Shareholder Value

Non-Registered Director Nam Dong-heun of NEXTBIOMEDICAL acquired 1,000 common shares through open market purchase on June 24, 2026 at 39,200 KRW per share, increasing his total holdings to 1,000 shares representing a 0.01% stake.
This small-scale purchase accounts for only 0.01% of total outstanding shares of 8,277,286, resulting in negligible dilution and no change in control.
[AI Summary]Although insider buying often signals confidence, the minimal size of this transaction provides no material impact on stock price outlook or shareholder value; future accumulation may be needed to influence the market.